Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHgCapital Trust plc Regulatory News (HGT)

Share Price Information for HgCapital Trust plc (HGT)

Share Price is delayed by 15 minutes
Get Live Data
400.00    -7.00 (-1.72%)
Bid:
399.00
Ask:
402.50
Spread: 3.50 (0.877%)
Market Cap: £1.81b
HGT Live PriceLast checked at - London Stock Exchange

Intraday HgCapital Trust plc Share Chart

Acquisition

5 Apr 2006 07:00

HG Capital Trust PLC05 April 2006 The following is the text of a press release issued by HgCapital, which managesthe investment portfolio of HgCapital Trust plc alongside those of otherinstitutional clients. The Trust, which is a listed investment trust givinginvestors the opportunity to participate in all of HgCapital's investments, willinvest approximately £12.2 million in Paragon Healthcare Group. HgCapital extends presence in specialist healthcare sector with the acquisitionof Paragon Healthcare Group for £322 million London, 5 April 2006. HgCapital, the European sector-focussed private equityinvestor, has acquired Paragon Healthcare Group ("Paragon") from Duke StreetCapital in a £322 million buy-out. Paragon is a leading provider of speciality community-based residential care forpeople with learning disabilities. Paragon operates more than 250 homes with1600 places throughout the UK. Its homes provide a normal and positive lifestylefor residents in a comfortable domestic living environment and present an idealplatform from which people can further develop and improve their adult lives.This community-based care is now the recognised standard for those with learningdisabilities and other complex needs. HgCapital has significant experience and expertise in the specialist caresector. In 2002, it acquired Castlebeck Care ("Castlebeck"), the UK's largestindependent provider of specialist healthcare and rehabilitation services forpatients with learning disabilities and severely challenging behaviours. Underthe ownership of HgCapital and management, Castlebeck has increased its capacityby more than 60% and has developed new specialist services both for young peopleand for those with autism. It has also extended its geographic reach across theUK. HgCapital will work with the existing Paragon management, who have invested inthe business, to grow Paragon. They see opportunities to continue to developservices in areas where there is a lack of good quality provision. Lindsay Dibden, Partner of HgCapital and Head of the Healthcare team commented:"Paragon is an excellent business which provides the best possible services to avulnerable section of the community. We are pleased to be backing a strongmanagement team, all of whom remain fully committed to the business. HgCapitalalready has a deep understanding of the specialist care sector which has stronglong term growth prospects." Douglas Quinn, Chief Executive of Paragon said:"Our commitment to the people we support is our absolute priority. There remainsa significant demand for the specialist care services we provide, which are nowrecognised as the most effective way of helping the development of people withlearning disabilities. HgCapital has a real understanding and commitment to thesector. They will support the continued growth of our business and improvementsof the care and services we provide. We are delighted with this newpartnership." HgCapital was advised by Merrill Lynch (corporate finance), Linklaters (legal),Deloitte (financial), PricewaterhouseCoopers (commercial), Willis (insurance),Christie & Co (property valuation), and Pinder Professional and ConsultancyServices (property). Contacts HgCapital Lindsay Dibden +44 (0)20 7089 7980Jill Ridley-Smith +44 (0)20 7089 7981 Maitland Suzanne Bartch +44 (0)20 7379 5151Peter Ogden This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
18th Sep 200811:48 amRNSAcquisition
16th Sep 20087:00 amRNSDisposal
10th Sep 20082:57 pmPRNPerformance at month end
28th Aug 20087:00 amPRNHalf-yearly Report
26th Jun 20083:41 pmPRNDirector/PDMR Shareholding
13th Jun 20082:07 pmRNSAcquisition
5th Jun 20085:05 pmPRNPerformance at month end
6th May 20082:20 pmPRNResult of AGM
6th May 20087:00 amPRNInterim Management Statement
11th Apr 200810:25 amRNSDisposal
4th Apr 20085:32 pmPRNPerformance at month end
18th Mar 20087:02 amRNSFinal Results - Part 2
18th Mar 20087:02 amRNSFinal Results - Part 1
21st Feb 20088:13 amRNSSale of Clarion
31st Jan 20084:40 pmPRNHolding(s) in Company
29th Jan 20087:01 amRNSDisposal
17th Jan 20082:56 pmPRNHolding(s) in Company
3rd Jan 20084:22 pmPRNPortfolio Update
24th Dec 200711:45 amPRNDirector/PDMR Shareholding
20th Dec 20074:55 pmPRNDirector/PDMR Shareholding
19th Dec 20072:25 pmRNSAcquisition
14th Dec 20073:39 pmPRNDirector/PDMR Shareholding
5th Dec 20074:52 pmPRNPerformance at Month End
30th Nov 20074:15 pmRNSSale of Hofmann Menu
20th Nov 20073:33 pmPRNHolding(s) in Company
5th Nov 20075:35 pmPRNPerformance at Month End
22nd Oct 20077:00 amPRNPerformance at month end - additional information
16th Oct 20074:20 pmPRNDirector/PDMR Shareholding
11th Oct 20073:42 pmPRNDirectorate Change
4th Oct 20075:22 pmPRNPerformance at month end
26th Sep 20077:03 amRNSAcquisition
19th Sep 20077:01 amRNSAcquisition
11th Sep 20077:00 amPRNHalf-yearly Report
21st Aug 20078:31 amRNSSale of Schenk Process
25th Jul 200711:45 amRNSAcquisition
11th Jun 20077:02 amRNSDisposal
8th Jun 20072:59 pmPRNPerformance at month end
4th Jun 20075:01 pmPRNPortfolio Update
9th May 200710:58 amPRNPerformance at month end
3rd May 200710:29 amRNSAcquisition
2nd May 20074:03 pmPRNPortfolio Update
27th Apr 20074:02 pmRNSSale of DocMorris
25th Apr 20072:54 pmPRNResult of AGM
23rd Apr 20072:36 pmPRNAnnual Information Update
16th Apr 20073:56 pmPRNPortfolio Update
30th Mar 20075:23 pmPRNAnnual Report and Special Business
13th Mar 20071:05 pmPRNDividend Declaration
13th Mar 20077:02 amRNSFinal Results
6th Mar 20074:28 pmPRNHolding(s) in Company
5th Mar 200710:43 amRNSAcquisition

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.